Kimberly Walker, M.S.

Bioinformatics Manager

Contact information

kimberly.walker@bcm.edu

Profile

Kimberly Walker, M.S. is a Bioinformatics Manager with eighteen years’ experience in Bioinformatics and Data Science. Ms. Walker has been with the HGSC since 2012.  In the preceding ten years she has gained experience in NGS data analysis for both clinical and research genomics spanning several projects including TCGA, UDN, eMERGE and most recently NIH’s All of Us project. Her experience includes R&D technology development for both emerging sequencing technologies and laboratory protocols as well as numerous panels, WES, WGS and RNAseq CAP/CLIA validations.

Publications

2024
Bhamidipati SV, Surathu A, Chao H, Agustinho DP, Xiang Q, Kottapalli K, et al.. Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment. bioRxiv. 2024;.

Venner E, Patterson K, Kalra D, Wheeler MM, Chen Y-J, Kalla SE, et al.. Author Correction: The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities. Commun Biol. 2024;7(1):713.

Venner E, Patterson K, Kalra D, Wheeler MM, Chen Y-J, Kalla SE, et al.. The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities. Commun Biol. 2024;7(1):174.

2022
Wang L, Scherer SE, Bielinski SJ, Muzny DM, Jones LA, Black JLogan, et al.. Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. Genet Med. 2022;24(5):1062-1072.

Venner E, Muzny DM, Smith JD, Walker K, Neben CL, Lockwood CM, et al.. Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program. Genome Med. 2022;14(1):34.

Walker K, Kalra D, Lowdon R, Chen G, Molik D, Soto DC, et al.. The third international hackathon for applying insights into large-scale genomic composition to use cases in a wide range of organisms. F1000Res. 2022;11:530.

2021
Gong B, Li D, Kusko R, Novoradovskaya N, Zhang Y, Wang S, et al.. Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions. Genome Biol. 2021;22(1):109.

2020
Bielinski SJ, St Sauver JL, Olson JE, Larson NB, Black JL, Scherer SE, et al.. Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol). Int J Epidemiol. 2020;49(1):23-24k.

2019
Beck CR, Carvalho CMB, Akdemir ZC, Sedlazeck FJ, Song X, Meng Q, et al.. Megabase Length Hypermutation Accompanies Human Structural Variation at 17p11.2. Cell. 2019;176(6):1310-1324.e10.

2018
Sanghvi RV, Buhay CJ, Powell BC, Tsai EA, Dorschner MO, Hong CS, et al.. Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers. Genet Med. 2018;20(8):855-866.

2016
Boone PM, Yuan B, Gu S, Ma Z, Gambin T, Gonzaga-Jauregui C, et al.. Hutterite-type cataract maps to chromosome 6p21.32-p21.31, cosegregates with a homozygous mutation in LEMD2, and is associated with sudden cardiac death. Mol Genet Genomic Med. 2016;4(1):77-94.

Gingras M-C, Covington KR, Chang DK, Donehower LA, Gill AJ, Ittmann MM, et al.. Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Rep. 2016;14(4):907-919.

2014
Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, et al.. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet. 2014;46(12):1267-73.